Sporimune 50 mg/ml oral solution for cats and dogs
Sporimune 50 mg/ml oral solution for cats and dogs
Authorised
- Ciclosporin
Product identification
Medicine name:
Sporimune 50 mg/ml oral solution for cats and dogs
SPORIMUNE 50 mg/ml SOLUCION ORAL PARA GATOS Y PERROS
Active substance:
- Ciclosporin
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Ciclosporin50.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QL04AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Package description:
- Brown glass bottles (type III) of 25 ml, closed with a child resistant closure (PP screw cap with a Teflon inlay).One bottle and a dispenser set (consisting of a child resistant HDPE screw cap and a 1 ml PP dosing syringe for cats and a 5 ml PP dosing syringe for dogs) packed in a cardboard box.
- Brown glass bottles (type III) of 50 ml, closed with a child resistant closure (PP screw cap with a Teflon inlay).One bottle and a dispenser set (consisting of a child resistant HDPE screw cap and a 1 ml PP dosing syringe for cats and a 5 ml PP dosing syringe for dogs) packed in a cardboard box.
- Brown glass bottles (type III) of 100 ml, closed with a child resistant closure (PP screw cap with a Teflon inlay).One bottle and a dispenser set (consisting of a child resistant HDPE screw cap and a 1 ml PP dosing syringe for cats and a 5 ml PP dosing syringe for dogs) packed in a cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 2903 ESP
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0302/001
Concerned member states:
-
Austria
-
Belgium
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 16/01/2026
Spanish (PDF)
Published on: 5/02/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 5/02/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 5/02/2025
Combined File of all Documents
English (PDF)
Download Published on: 19/01/2025